Annovis Bio Inc.

NYSE: ANVS · Real-Time Price · USD
2.73
0.01 (0.37%)
At close: Aug 15, 2025, 3:59 PM
2.72
-0.37%
After-hours: Aug 15, 2025, 05:59 PM EDT

Annovis Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-17.41M -25.17M -26.7M -30.4M -40.88M -42.88M -25.09M -17.82M -9.44M -8.44M -23.66M -26.41M -22.78M -16.56M -14.54M -10.53M -9.28M -9.29M
Interest Income
191.84M 475.29K 331.85K 271.71K 282.93K 479.53K 667.9K 675.92K 582.15K 395.6K 182.71K 114.01K 66.68K 30.65K 11K 5.55K n/a n/a
Pretax Income
-6.24B -29.06M -24.59M -40.94M -43.02M -47.53M -56.2M -37.09M -29.99M -29.17M -24.67M -27.49M -22.71M -16.52M -14.49M -10.28M -8.44M -8.22M
Net Income
-6.24B -29.06M -24.59M -40.94M -43.02M -47.53M -56.2M -37.01M -29.81M -28.92M -24.42M -27.31M -22.64M -16.52M -14.49M -10.28M -8.44M -8.22M
Selling & General & Admin
2.38B 1.28B 6.71M 6.51M 5.84M 5.36M 6.25M 6.3M 7.63M 8.07M 8.99M 10.44M 9.55M 8.32M 6.06M 3.52M 2.93M 3.91M
Research & Development
10.18B 5.02B 19.99M 23.89M 35.04M 37.52M 38.79M 31.46M 22.94M 21.49M 16.52M 17.82M 13.89M 8.9M 8.48M 7.01M 6.35M 5.38M
Other Expenses
-6.28B -6.28B 579.00 -421 -1.42K -2K -2K -1K n/a n/a n/a n/a n/a -7.41K -7.41K -7.41K -7.41K n/a
Operating Expenses
6.29B 25.17M 26.7M 30.4M 40.88M 42.88M 45.03M 37.76M 29.38M 28.38M 23.66M 26.41M 22.78M 16.55M 14.5M 10.49M 9.24M 9.26M
Interest Expense
524.07K 1.87M 1.87M 1.87M 1.35M n/a n/a n/a n/a n/a n/a n/a n/a 2.13K 2.33K 2.54K 13.04K 36.79K
Selling & Marketing Expenses
-1.7B -1.7B -1.7B -1.7B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
17.41M 25.17M 26.7M 30.4M 40.88M 42.88M 45.03M 37.76M 29.38M 28.38M 13.15M 15.9M 12.27M 6.05M 14.5M 10.49M 9.24M 9.26M
Income Tax Expense
-5 -5 -2 -10.44K -10.44K -20.2K 19.69M 19.62M 19.52M 19.45M -291.5K -228.25K -122.25K -50.2K -10.9K n/a n/a n/a
Shares Outstanding (Basic)
19.49M 12.18M 13.79M 12.98M 11.31M 10.63M 9.53M 9.01M 8.95M 8.2M 8.16M 8.16M 8.16M 8.16M 8.1M 8.1M 7.37M 6.92M
Shares Outstanding (Diluted)
19.49M 12.23M 13.79M 12.98M 11.31M 10.63M 9.53M 9.01M 8.95M 8.2M 8.16M 8.16M 8.16M 8.16M 8.1M 8.1M 7.37M 6.92M
EPS (Basic)
-2.04 -2.16 -1.94 -3.84 -4.5 -5.13 -8.62 -6.66 -5.82 -5.81 -2.94 -3.3 -2.86 -2.14 -1.88 -1.4 -1.2 -1.2
EPS (Diluted)
-2.22 -2.34 -1.99 -3.84 -4.5 -5.13 -8.62 -6.66 -5.95 -5.94 -3.07 -3.43 -2.86 -2.14 -1.88 -1.4 -1.2 -1.2
EBITDA
-17.41M -25.17M -26.7M -30.4M -40.88M -42.88M -45.03M -37.76M -29.38M -25.6M -20.88M -23.63M -20M -16.55M -14.5M -10.29M -6.85M -6.65M
EBIT
-17.41M -25.17M -26.7M -30.4M -40.88M -42.65M -44.58M -41.94M -34.7M -33.88M -29.39M -27.51M -22.74M -16.55M -14.49M -10.28M -8.45M -8.26M
Depreciation & Amortization
5.00 5.00 2.00 1.00 14.86M 24.62M 34.59M 42.39M 34.02M 30.23M 25.51M 23.63M 20M 16.56M 14.54M 10.53M 9.28M 9.29M